FDA Device Intelligence
HomeMaquet Cardiopulmonary AG › MACE

MACE

Maquet Cardiopulmonary AG · Model BO-VHK 11000, SOFTLINE, Neonatal, Sterile · UDI-DI 04037691665726

DTNDTP Prescription
10
510(k) clearances
490
Adverse events (24 deaths)
47
Recalls
32
Facilities

Description

Neonatal Venous Hardshell Cardiotomy Reservoir (MACE) neonatal with SOFTLINE Coating, vacuum-tight, Sterile. The Neonatal (VHK 11000) Venous Hardshell Cardiotomy Reservoirs are developed for the use in the field cardiopulmonary bypass operation. They are used as blood buffer in the extracorporeal circuit and as collecting and defoaming device for sucked blood. Both reservoirs are of identical design, differing only in the size, to enable the defined performance within flow rates, required for neonatal or pediatric patients. The reservoirs can also be employed postoperatively as drainage and autotransfusion reservoir (e.g., for thorax drainage) to return the autologous blood to the patient which was removed from the thorax for the volume exchange.

Recalls

DateFirmReason
2023-05-18Maquet Medical Systems USA1. An accessory may be improperly placed during packaging, causing creases and damage to the accessory's sterile pouch. 2. Product packaging may exhibit holes, cracks, dents, and c
2021-04-27Circulatory Technology Inc.The device is used as part of extracorporeal membrane oxygenation (ECMO) cardiopulmonary bypass circuits and may collapse during use which can increase resistance to flow in the ve
2021-02-04Medtronic Perfusion SystemsProducts being recalled due to potentially elevated level of bacterial endotoxin. Patients exposed to elevated levels of bacterial endotoxins may develop an acute inflammatory resp
2021-02-04Medtronic Perfusion SystemsProducts being recalled due to potentially elevated level of bacterial endotoxin. Patients exposed to elevated levels of bacterial endotoxins may develop an acute inflammatory resp
2021-02-04Medtronic Perfusion SystemsProducts being recalled due to potentially elevated level of bacterial endotoxin. Patients exposed to elevated levels of bacterial endotoxins may develop an acute inflammatory resp
2021-02-04Medtronic Perfusion SystemsProducts being recalled due to potentially elevated level of bacterial endotoxin. Patients exposed to elevated levels of bacterial endotoxins may develop an acute inflammatory resp
2021-02-04Medtronic Perfusion SystemsProducts being recalled due to potentially elevated level of bacterial endotoxin. Patients exposed to elevated levels of bacterial endotoxins may develop an acute inflammatory resp
2021-02-04Medtronic Perfusion SystemsProducts being recalled due to potentially elevated level of bacterial endotoxin. Patients exposed to elevated levels of bacterial endotoxins may develop an acute inflammatory resp
2021-02-04Medtronic Perfusion SystemsProducts being recalled due to potentially elevated level of bacterial endotoxin. Patients exposed to elevated levels of bacterial endotoxins may develop an acute inflammatory resp
2021-02-04Medtronic Perfusion SystemsProducts being recalled due to potentially elevated level of bacterial endotoxin. Patients exposed to elevated levels of bacterial endotoxins may develop an acute inflammatory resp

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.